Market Cap
Low in industry
PE TTM
Negative PE TTM
PEG TTM
Price to Book
Negative Price to Book
Beta 1Year
Very Low volatility
Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|
L. Robert Nussbaum | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.65 per share. | 20 Dec 2023 | 17,404 | 551,941 (0%) | 0% | 0.6 | 11,278 | Common Stock |
Thomas Brida R. | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.65 per share. | 20 Dec 2023 | 17,404 | 916,183 (0%) | 0% | 0.6 | 11,278 | Common Stock |
David B. Sholehvar | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2023 | 850,000 | 850,000 (0%) | 0% | 0 | Common Stock | |
Thomas R. Brida | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2023 | 229,500 | 933,587 (0%) | 0% | 0 | Common Stock | |
Ana J. Schrank | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 850,000 | 850,000 (0%) | 0% | 0 | Common Stock | |
Robert M. Guigley | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2023 | 850,000 | 850,000 (0%) | 0% | 0 | Common Stock | |
Thomas R. Brida | See Remarks | Sale of securities on an exchange or to another person at price $ 1.38 per share. | 13 Jun 2023 | 7,079 | 704,087 (0%) | 0% | 1.4 | 9,748 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.38 per share. | 13 Jun 2023 | 7,086 | 569,345 (0%) | 0% | 1.4 | 9,757 | Common Stock |
Kenneth D. Knight | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.20 per share. | 16 May 2023 | 45,432 | 1,671,610 (1%) | 0% | 1.2 | 54,487 | Common Stock |
Thomas R. Brida | See Remarks | Sale of securities on an exchange or to another person at price $ 1.20 per share. | 16 May 2023 | 26,476 | 711,166 (0%) | 0% | 1.2 | 31,753 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.20 per share. | 16 May 2023 | 26,476 | 576,431 (0%) | 0% | 1.2 | 31,753 | Common Stock |
Robert F. Werner | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 1.20 per share. | 16 May 2023 | 21,559 | 354,748 (0%) | 0% | 1.2 | 25,856 | Common Stock |
Yafei Wen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.20 per share. | 16 May 2023 | 43,452 | 700,297 (0%) | 0% | 1.2 | 52,112 | Common Stock |
Christine M. Gorjanc | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 70,422 | 111,022 (0%) | 0% | 0 | Common Stock | |
Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 86,705 | 86,705 | - | - | Stock Option (right to buy) | |
Kimber D. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 70,422 | 111,022 (0%) | 0% | 0 | Common Stock | |
Kimber D. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 28,901 | 28,901 | - | - | Stock Option (right to buy) | |
Chitra Nayak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 70,422 | 111,022 (0%) | 0% | 0 | Common Stock | |
Chitra Nayak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 28,901 | 28,901 | - | - | Stock Option (right to buy) | |
Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 70,422 | 125,322 (0%) | 0% | 0 | Common Stock | |
Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 28,901 | 28,901 | - | - | Stock Option (right to buy) | |
Christine M. Gorjanc | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 28,901 | 28,901 | - | - | Stock Option (right to buy) | |
Geoffrey S. Crouse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 28,901 | 28,901 | - | - | Stock Option (right to buy) | |
Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 70,422 | 161,222 (0%) | 0% | 0 | Common Stock | |
Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 28,901 | 28,901 | - | - | Stock Option (right to buy) | |
William H. Osborne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 7,225 | 7,225 | - | - | Stock Option (right to buy) | |
William H. Osborne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 28,901 | 28,901 | - | - | Stock Option (right to buy) | |
William H. Osborne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 17,605 | 158,450 (0%) | 0% | 0 | Common Stock | |
William H. Osborne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 70,422 | 140,845 (0%) | 0% | 0 | Common Stock | |
Geoffrey S. Crouse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 70,422 | 130,281 (0%) | 0% | 0 | Common Stock | |
Robert F. Werner | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 120,000 | 371,307 (0%) | 0% | 0 | Common Stock | |
Robert L. Nussbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 155,000 | 602,907 (0%) | 0% | 0 | Common Stock | |
Thomas R. Brida | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 300,000 | 737,642 (0%) | 0% | 0 | Common Stock | |
Kenneth D. Knight | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 1,200,000 | 1,717,042 (1%) | 1% | 0 | Common Stock | |
Yafei Wen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 300,000 | 743,749 (0%) | 0% | 0 | Common Stock | |
Yafei Wen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.41 per share. | 13 Mar 2023 | 2,625 | 443,749 (0%) | 0% | 1.4 | 3,701 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.41 per share. | 13 Mar 2023 | 2,625 | 447,907 (0%) | 0% | 1.4 | 3,701 | Common Stock |
Thomas R. Brida | See Remarks | Sale of securities on an exchange or to another person at price $ 1.41 per share. | 13 Mar 2023 | 2,625 | 437,642 (0%) | 0% | 1.4 | 3,701 | Common Stock |
Kenneth D. Knight | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.41 per share. | 13 Mar 2023 | 1,853 | 517,042 (0%) | 0% | 1.4 | 2,613 | Common Stock |
William H. Osborne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 70,423 | 70,423 (0%) | 0% | 0 | Common Stock | |
William H. Osborne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 28,902 | 28,902 | - | - | Stock Option (right to buy) | |
Sean E. George | Director | Sale of securities on an exchange or to another person at price $ 2.04 per share. | 16 Dec 2022 | 44,816 | 743,840 (0%) | 0% | 2.0 | 91,420 | Common Stock |
Sean E. George | Director | Sale of securities on an exchange or to another person at price $ 2.08 per share. | 16 Dec 2022 | 11,163 | 732,677 (0%) | 0% | 2.1 | 23,210 | Common Stock |
Robert F. Werner | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 3.45 per share. | 25 Aug 2022 | 1,350 | 251,307 (0%) | 0% | 3.5 | 4,658 | Common Stock |
Robert F. Werner | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Aug 2022 | 54,000 | 252,657 (0%) | 0% | 0 | Common Stock | |
Robert L. Nussbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Aug 2022 | 54,000 | 450,532 (0%) | 0% | 0 | Common Stock | |
Thomas R. Brida | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Aug 2022 | 54,000 | 440,267 (0%) | 0% | 0 | Common Stock | |
Yafei Wen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Aug 2022 | 102,000 | 446,374 (0%) | 0% | 0 | Common Stock | |
Robert F. Werner | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 4.55 per share. | 16 Aug 2022 | 3,252 | 198,657 (0%) | 0% | 4.6 | 14,798 | Common Stock |
Sean E. George | Director | Sale of securities on an exchange or to another person at price $ 4.55 per share. | 16 Aug 2022 | 22,085 | 788,656 (0%) | 0% | 4.6 | 100,493 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 4.55 per share. | 16 Aug 2022 | 7,048 | 396,532 (0%) | 0% | 4.6 | 32,071 | Common Stock |
Thomas R. Brida | See remarks | Sale of securities on an exchange or to another person at price $ 4.55 per share. | 16 Aug 2022 | 7,048 | 386,267 (0%) | 0% | 4.6 | 32,071 | Common Stock |
Sean E. George | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2022 | 8,050 | 8,050 | - | - | Employee Stock Option (right to buy) | |
Sean E. George | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2022 | 16,050 | 810,741 (0%) | 0% | 0 | Common Stock | |
Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2022 | 4,275 | 4,275 | - | - | Employee Stock Option (right to buy) | |
Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2022 | 22,730 | 22,730 | - | - | Employee Stock Option (right to buy) | |
Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2022 | 8,475 | 90,800 (0%) | 0% | 0 | Common Stock | |
Randal W. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2022 | 45,325 | 82,325 (0%) | 0% | 0 | Common Stock | |
Kenneth D. Knight | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2022 | 1,000,000 | 1,000,000 | - | - | Employee Stock Option (right to buy) | |
Robert F. Werner | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 3.81 per share. | 17 May 2022 | 7,356 | 204,655 (0%) | 0% | 3.8 | 28,027 | Common Stock |
Robert F. Werner | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 3.40 per share. | 17 May 2022 | 2,746 | 201,909 (0%) | 0% | 3.4 | 9,336 | Common Stock |
Sean E. George | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 3.81 per share. | 17 May 2022 | 18,296 | 794,691 (0%) | 0% | 3.8 | 69,710 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 3.81 per share. | 17 May 2022 | 6,098 | 403,580 (0%) | 0% | 3.8 | 23,234 | Common Stock |
Thomas R. Brida | See Remarks | Sale of securities on an exchange or to another person at price $ 3.81 per share. | 17 May 2022 | 6,098 | 393,315 (0%) | 0% | 3.8 | 23,234 | Common Stock |
Kenneth D. Knight | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 3.81 per share. | 17 May 2022 | 28,295 | 518,895 (0%) | 0% | 3.8 | 107,807 | Common Stock |
Yafei Wen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.81 per share. | 17 May 2022 | 17,042 | 344,374 (0%) | 0% | 3.8 | 64,932 | Common Stock |
Christine M. Gorjanc | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 32,100 | 40,600 (0%) | 0% | 0 | Common Stock | |
Christine M. Gorjanc | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 16,100 | 16,100 | - | - | Stock Option (right to buy) | |
Geoffrey S. Crouse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 32,100 | 59,859 (0%) | 0% | 0 | Common Stock | |
Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 32,100 | 43,600 (0%) | 0% | 0 | Common Stock | |
Chitra Nayak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 16,100 | 16,100 | - | - | Stock Option (right to buy) | |
Chitra Nayak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 32,100 | 40,600 (0%) | 0% | 0 | Common Stock | |
Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 5,700 | 5,700 | - | - | Stock Option (right to buy) | |
Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 11,300 | 54,900 (0%) | 0% | 0 | Common Stock | |
Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 16,100 | 16,100 | - | - | Stock Option (right to buy) | |
Kimber D. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 32,100 | 40,600 (0%) | 0% | 0 | Common Stock | |
Kimber D. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 16,100 | 16,100 | - | - | Stock Option (right to buy) | |
Geoffrey S. Crouse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 16,100 | 16,100 | - | - | Stock Option (right to buy) | |
Robert F. Werner | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2022 | 135,815 | 209,795 (0%) | 0% | 0 | Common Stock | |
Robert L. Nussbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2022 | 168,511 | 409,678 (0%) | 0% | 0 | Common Stock | |
Thomas R. Brida | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2022 | 168,511 | 398,250 (0%) | 0% | 0 | Common Stock | |
Kenneth D. Knight | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2022 | 225,000 | 547,190 (0%) | 0% | 0 | Common Stock | |
Yafei Wen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2022 | 225,000 | 361,416 (0%) | 0% | 0 | Common Stock | |
Yafei Wen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2022 | 14,705 | 139,705 (0%) | 0% | 0 | Common Stock | |
Yafei Wen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.69 per share. | 12 Mar 2022 | 3,289 | 136,416 (0%) | 0% | 6.7 | 21,992 | Common Stock |
Kenneth D. Knight | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2022 | 14,705 | 324,548 (0%) | 0% | 0 | Common Stock | |
Kenneth D. Knight | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.69 per share. | 12 Mar 2022 | 2,358 | 322,190 (0%) | 0% | 6.7 | 15,767 | Common Stock |
Thomas R. Brida | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2022 | 14,705 | 247,726 (0%) | 0% | 0 | Common Stock | |
Thomas R. Brida | General Counsel | Sale of securities on an exchange or to another person at price $ 6.69 per share. | 12 Mar 2022 | 17,987 | 229,739 (0%) | 0% | 6.7 | 120,286 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 6.69 per share. | 12 Mar 2022 | 19,588 | 241,167 (0%) | 0% | 6.7 | 130,993 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2022 | 14,705 | 260,755 (0%) | 0% | 0 | Common Stock | |
Sean E. George | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2022 | 44,117 | 844,376 (0%) | 0% | 0 | Common Stock | |
Sean E. George | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 6.69 per share. | 12 Mar 2022 | 31,389 | 812,987 (0%) | 0% | 6.7 | 209,886 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2021 | 16,406 | 53,594 | - | - | Employee Stock Options (right to buy) | |
Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2021 | 13,269 | 40,080 | - | - | Employee Stock Options (right to buy) | |
Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.89 per share. | 11 Nov 2021 | 29,675 | 246,050 (0%) | 0% | 21.9 | 649,568 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.23 per share. | 11 Nov 2021 | 16,406 | 275,725 (0%) | 0% | 10.2 | 167,833 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.90 per share. | 11 Nov 2021 | 13,269 | 259,319 (0%) | 0% | 9.9 | 131,363 | Common Stock |
Sean E. George | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 28.06 per share. | 22 Oct 2021 | 3,675 | 800,259 (0%) | 0% | 28.1 | 103,121 | Common Stock |
Sean E. George | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.70 per share. | 27 Sep 2021 | 5,000 | 803,934 (0%) | 0% | 8.7 | 43,500 | Common Stock |
Sean E. George | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Sep 2021 | 5,000 | 35,000 | - | - | Employee Stock Options (right to buy) | |
Sean E. George | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Sep 2021 | 50,000 | 0 | - | - | Employee Stock Options (right to buy) | |
Sean E. George | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.42 per share. | 27 Sep 2021 | 50,000 | 798,934 (0%) | 0% | 3.4 | 171,000 | Common Stock |
Sean E. George | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 31.88 per share. | 22 Sep 2021 | 7,350 | 748,934 (0%) | 0% | 31.9 | 234,306 | Common Stock |
Robert F. Werner | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 24.86 per share. | 19 Aug 2021 | 15,337 | 73,980 (0%) | 0% | 24.9 | 381,318 | Common Stock |
Robert F. Werner | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 25.42 per share. | 16 Aug 2021 | 3,012 | 89,317 (0%) | 0% | 25.4 | 76,557 | Common Stock |
Sean E. George | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 25.42 per share. | 16 Aug 2021 | 16,986 | 756,284 (0%) | 0% | 25.4 | 431,737 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 25.42 per share. | 16 Aug 2021 | 21,231 | 246,050 (0%) | 0% | 25.4 | 539,633 | Common Stock |
Thomas R. Brida | General Counsel | Sale of securities on an exchange or to another person at price $ 25.42 per share. | 16 Aug 2021 | 14,438 | 232,537 (0%) | 0% | 25.4 | 366,975 | Common Stock |
Sean E. George | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 29.39 per share. | 22 Jul 2021 | 3,675 | 773,270 (0%) | 0% | 29.4 | 108,008 | Common Stock |
Sean E. George | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 33.02 per share. | 22 Jun 2021 | 3,675 | 776,945 (0%) | 0% | 33.0 | 121,363 | Common Stock |
Yafei Wen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2021 | 125,000 | 125,000 (0%) | 0% | 0 | Common Stock | |
Kenneth D. Knight | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 30.30 per share. | 15 Jun 2021 | 14,874 | 309,843 (0%) | 0% | 30.3 | 450,687 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 31.58 per share. | 14 Jun 2021 | 11,506 | 223,065 (0%) | 0% | 31.6 | 363,303 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 31.63 per share. | 14 Jun 2021 | 8,834 | 214,231 (0%) | 0% | 31.6 | 279,376 | Common Stock |
Shelly D. Guyer | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 31.63 per share. | 14 Jun 2021 | 9,910 | 241,975 (0%) | 0% | 31.6 | 313,405 | Common Stock |
Sean E. George | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 31.63 per share. | 14 Jun 2021 | 21,201 | 779,244 (0%) | 0% | 31.6 | 670,484 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 31.63 per share. | 14 Jun 2021 | 9,910 | 266,879 (0%) | 0% | 31.6 | 313,405 | Common Stock |
Thomas R. Brida | General Counsel | Sale of securities on an exchange or to another person at price $ 31.63 per share. | 14 Jun 2021 | 9,910 | 246,975 (0%) | 0% | 31.6 | 313,405 | Common Stock |
Robert F. Werner | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 27.62 per share. | 20 May 2021 | 7,116 | 92,329 (0%) | 0% | 27.6 | 196,560 | Common Stock |
Sean E. George | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 28.00 per share. | 20 May 2021 | 3,675 | 800,445 (0%) | 0% | 28 | 102,900 | Common Stock |
Robert F. Werner | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 18 May 2021 | 1,469 | 104,021 (0%) | 0% | 0 | Common Stock | |
Robert F. Werner | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 18 May 2021 | 346 | 105,752 (0%) | 0% | 0 | Common Stock | |
Robert F. Werner | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 18 May 2021 | 3,576 | 99,445 (0%) | 0% | 0 | Common Stock | |
Robert F. Werner | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 18 May 2021 | 1,000 | 103,021 (0%) | 0% | 0 | Common Stock | |
Robert F. Werner | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 18 May 2021 | 262 | 105,490 (0%) | 0% | 0 | Common Stock | |
Kenneth D. Knight | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 27.49 per share. | 18 May 2021 | 28,010 | 324,717 (0%) | 0% | 27.5 | 769,872 | Common Stock |
Shelly D. Guyer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2021 | 27,000 | 255,309 (0%) | 0% | 0 | Common Stock | |
Shelly D. Guyer | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 27.49 per share. | 06 May 2021 | 3,424 | 251,885 (0%) | 0% | 27.5 | 94,111 | Common Stock |
Christine M. Gorjanc | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 8,500 | 8,500 (0%) | 0% | 0 | Common Stock | |
Christine M. Gorjanc | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 4,400 | 4,400 | - | - | Stock Option (right to buy) | |
Geoffrey S. Crouse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 8,500 | 27,759 (0%) | 0% | 0 | Common Stock | |
Geoffrey S. Crouse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 4,400 | 4,400 | - | - | Stock Option (right to buy) | |
Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 8,500 | 8,500 (0%) | 0% | 0 | Common Stock | |
Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 1,500 | 1,500 | - | - | Stock Option (right to buy) | |
Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 3,000 | 11,500 (0%) | 0% | 0 | Common Stock | |
Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 4,400 | 4,400 | - | - | Stock Option (right to buy) | |
Katherine A. Stueland | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 23,200 | 23,200 | - | - | Employee Stock Option (right to buy) | |
Katherine A. Stueland | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 44,700 | 234,571 (0%) | 0% | 0 | Common Stock | |
Robert F. Werner | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 47,700 | 106,098 (0%) | 0% | 0 | Common Stock | |
Sean E. George | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 134,200 | 804,120 (0%) | 0% | 0 | Common Stock | |
Sean E. George | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 69,500 | 69,500 | - | - | Employee Stock Option (right to buy) | |
Robert L. Nussbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 23,200 | 23,200 | - | - | Employee Stock Option (right to buy) | |
Robert L. Nussbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 44,700 | 276,789 (0%) | 0% | 0 | Common Stock | |
Thomas R. Brida | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 44,700 | 256,461 (0%) | 0% | 0 | Common Stock | |
Thomas R. Brida | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 23,200 | 23,200 | - | - | Employee Stock Option (right to buy | |
Chitra Nayak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 8,500 | 8,500 (0%) | 0% | 0 | Common Stock | |
Chitra Nayak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 4,400 | 4,400 | - | - | Stock Option (right to buy) | |
Kimber D. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 4,400 | 4,400 | - | - | Stock Option (right to buy) | |
Kimber D. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 8,500 | 8,500 (0%) | 0% | 0 | Common Stock | |
Kenneth D. Knight | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 23,200 | 23,200 | - | - | Employee Stock Option (right to buy) | |
Kenneth D. Knight | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 44,700 | 352,727 (0%) | 0% | 0 | Common Stock | |
Sean E. George | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 36.94 per share. | 22 Apr 2021 | 1,299 | 669,920 (0%) | 0% | 36.9 | 47,979 | Common Stock |
Sean E. George | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 36.17 per share. | 22 Apr 2021 | 2,376 | 671,219 (0%) | 0% | 36.2 | 85,938 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 39.38 per share. | 14 Apr 2021 | 9,994 | 199,770 (0%) | 0% | 39.4 | 393,527 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 41.02 per share. | 14 Apr 2021 | 100 | 189,871 (0%) | 0% | 41.0 | 4,102 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 40.37 per share. | 14 Apr 2021 | 9,799 | 189,971 (0%) | 0% | 40.4 | 395,581 | Common Stock |
Sean E. George | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 42.89 per share. | 22 Mar 2021 | 1,825 | 674,196 (0%) | 0% | 42.9 | 78,276 | Common Stock |
Sean E. George | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 43.51 per share. | 22 Mar 2021 | 601 | 673,595 (0%) | 0% | 43.5 | 26,148 | Common Stock |
Sean E. George | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 41.77 per share. | 22 Mar 2021 | 1,249 | 676,021 (0%) | 0% | 41.8 | 52,172 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 42.90 per share. | 15 Mar 2021 | 5,781 | 209,764 (0%) | 0% | 42.9 | 248,008 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 42.90 per share. | 15 Mar 2021 | 6,265 | 232,089 (0%) | 0% | 42.9 | 268,772 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 42.90 per share. | 15 Mar 2021 | 11,894 | 238,354 (0%) | 0% | 42.9 | 510,260 | Common Stock |
Thomas R. Brida | General Counsel | Sale of securities on an exchange or to another person at price $ 42.90 per share. | 15 Mar 2021 | 6,265 | 211,761 (0%) | 0% | 42.9 | 268,772 | Common Stock |
Thomas R. Brida | General Counsel | Sale of securities on an exchange or to another person at price $ 42.90 per share. | 15 Mar 2021 | 9,786 | 218,026 (0%) | 0% | 42.9 | 419,825 | Common Stock |
Shelly D. Guyer | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 42.90 per share. | 12 Mar 2021 | 11,882 | 234,574 (0%) | 0% | 42.9 | 509,745 | Common Stock |
Shelly D. Guyer | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 42.90 per share. | 12 Mar 2021 | 6,265 | 228,309 (0%) | 0% | 42.9 | 268,772 | Common Stock |
Shelly D. Guyer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 24,936 | 246,456 (0%) | 0% | 0 | Common Stock | |
Sean E. George | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 42.90 per share. | 12 Mar 2021 | 13,992 | 696,445 (0%) | 0% | 42.9 | 600,265 | Common Stock |
Sean E. George | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 53,436 | 710,437 (0%) | 0% | 0 | Common Stock | |
Sean E. George | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Mar 2021 | 5,750 | 677,270 (0%) | 0% | 0 | Common Stock | |
Sean E. George | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 42.90 per share. | 12 Mar 2021 | 13,425 | 683,020 (0%) | 0% | 42.9 | 575,941 | Common Stock |
Sean E. George | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2021 | 23,333 | 0 | - | - | Employee Stock Options (right to buy) | |
Sean E. George | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.26 per share. | 09 Mar 2021 | 23,333 | 657,001 (0%) | 0% | 1.3 | 29,400 | Common Stock |
Sean E. George | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 37.24 per share. | 04 Mar 2021 | 1,200 | 634,068 (0%) | 0% | 37.2 | 44,684 | Common Stock |
Sean E. George | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 39.16 per share. | 04 Mar 2021 | 100 | 633,668 (0%) | 0% | 39.2 | 3,916 | Common Stock |
Sean E. George | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 38.09 per share. | 04 Mar 2021 | 300 | 633,768 (0%) | 0% | 38.1 | 11,427 | Common Stock |
Sean E. George | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 36.01 per share. | 04 Mar 2021 | 2,075 | 635,268 (0%) | 0% | 36.0 | 74,724 | Common Stock |
Shelly D. Guyer | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 44.17 per share. | 02 Mar 2021 | 300 | 221,520 (0%) | 0% | 44.2 | 13,250 | Common Stock |
Shelly D. Guyer | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 43.34 per share. | 02 Mar 2021 | 1,100 | 221,820 (0%) | 0% | 43.3 | 47,672 | Common Stock |
Shelly D. Guyer | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 42.50 per share. | 02 Mar 2021 | 1,600 | 222,920 (0%) | 0% | 42.5 | 68,003 | Common Stock |
Thomas R. Brida | General Counsel | Sale of securities on an exchange or to another person at price $ 41.50 per share. | 01 Mar 2021 | 200 | 207,676 (0%) | 0% | 41.5 | 8,300 | Common Stock |
Thomas R. Brida | General Counsel | Sale of securities on an exchange or to another person at price $ 43.96 per share. | 01 Mar 2021 | 3,319 | 202,876 (0%) | 0% | 44.0 | 145,894 | Common Stock |
Thomas R. Brida | General Counsel | Sale of securities on an exchange or to another person at price $ 43.35 per share. | 01 Mar 2021 | 1,481 | 206,195 (0%) | 0% | 43.3 | 64,196 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 40.97 per share. | 25 Feb 2021 | 1,300 | 203,352 (0%) | 0% | 41.0 | 53,260 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 39.65 per share. | 25 Feb 2021 | 2,300 | 204,652 (0%) | 0% | 39.7 | 91,196 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.23 per share. | 25 Feb 2021 | 5,000 | 208,052 (0%) | 0% | 10.2 | 51,150 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 38.95 per share. | 25 Feb 2021 | 1,100 | 206,952 (0%) | 0% | 38.9 | 42,844 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2021 | 5,000 | 35,000 | - | - | Employee Stock Options (Right to Buy) | |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 41.75 per share. | 25 Feb 2021 | 300 | 203,052 (0%) | 0% | 41.7 | 12,524 | Common Stock |
Geoffrey S. Crouse | Director | Sale of securities on an exchange or to another person at price $ 48.43 per share. | 22 Feb 2021 | 7,800 | 21,459 (0%) | 0% | 48.4 | 377,732 | Common Stock |
Geoffrey S. Crouse | Director | Sale of securities on an exchange or to another person at price $ 49.30 per share. | 22 Feb 2021 | 2,200 | 19,259 (0%) | 0% | 49.3 | 108,451 | Common Stock |
Jason W. Myers | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Feb 2021 | 310,597 | 100,000 (0%) | 0% | 0 | Common Stock | |
Sean E. George | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 53.60 per share. | 21 Jan 2021 | 7,003 | 639,015 (0%) | 0% | 53.6 | 375,395 | Common Stock |
Sean E. George | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2021 | 5,000 | 40,000 | - | - | Employee Stock Options (right to buy) | |
Sean E. George | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 55.69 per share. | 21 Jan 2021 | 400 | 637,343 (0%) | 0% | 55.7 | 22,275 | Common Stock |
Sean E. George | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 54.27 per share. | 21 Jan 2021 | 1,272 | 637,743 (0%) | 0% | 54.3 | 69,033 | Common Stock |
Sean E. George | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.70 per share. | 21 Jan 2021 | 5,000 | 646,018 (0%) | 0% | 8.7 | 43,500 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.94 per share. | 13 Jan 2021 | 4,199 | 207,251 (0%) | 0% | 10.9 | 45,937 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2021 | 4,199 | 25,801 | - | - | Employee Stock Options (Right to Buy) | |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 53.22 per share. | 13 Jan 2021 | 400 | 203,052 (0%) | 0% | 53.2 | 21,290 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 52.71 per share. | 13 Jan 2021 | 1,600 | 203,452 (0%) | 0% | 52.7 | 84,330 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 51.55 per share. | 13 Jan 2021 | 1,567 | 205,052 (0%) | 0% | 51.5 | 80,777 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 49.88 per share. | 13 Jan 2021 | 400 | 206,619 (0%) | 0% | 49.9 | 19,951 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 48.50 per share. | 13 Jan 2021 | 232 | 207,019 (0%) | 0% | 48.5 | 11,251 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.90 per share. | 06 Jan 2021 | 10,101 | 225,312 (0%) | 0% | 9.9 | 100,000 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2021 | 10,101 | 53,349 | - | - | Employee Stock Options (right to buy) | |
Kenneth D. Knight | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 50.50 per share. | 24 Dec 2020 | 3,622 | 308,027 (0%) | 0% | 50.5 | 182,911 | Common Stock |
Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 50.58 per share. | 23 Dec 2020 | 400 | 410,597 (0%) | 0% | 50.6 | 20,230 | Common Stock |
Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 49.77 per share. | 23 Dec 2020 | 3,752 | 410,997 (0%) | 0% | 49.8 | 186,732 | Common Stock |
Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 51.54 per share. | 23 Dec 2020 | 66,421 | 518,328 (0%) | 0% | 51.5 | 3,423,564 | Common Stock |
Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 52.62 per share. | 23 Dec 2020 | 53,653 | 464,675 (0%) | 0% | 52.6 | 2,823,355 | Common Stock |
Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 53.38 per share. | 23 Dec 2020 | 5,007 | 459,668 (0%) | 0% | 53.4 | 267,293 | Common Stock |
Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 54.04 per share. | 23 Dec 2020 | 100 | 459,568 (0%) | 0% | 54.0 | 5,404 | Common Stock |
Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 47.03 per share. | 23 Dec 2020 | 24,161 | 435,407 (0%) | 0% | 47.0 | 1,136,270 | Common Stock |
Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 47.85 per share. | 23 Dec 2020 | 5,858 | 429,549 (0%) | 0% | 47.8 | 280,300 | Common Stock |
Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 49.04 per share. | 23 Dec 2020 | 14,800 | 414,749 (0%) | 0% | 49.0 | 725,730 | Common Stock |
Sean E. George | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 52.95 per share. | 22 Dec 2020 | 2,739 | 631,718 (0%) | 0% | 52.9 | 145,019 | Common Stock |
Sean E. George | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 53.99 per share. | 22 Dec 2020 | 700 | 631,018 (0%) | 0% | 54.0 | 37,793 | Common Stock |
Sean E. George | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 51.62 per share. | 22 Dec 2020 | 236 | 634,457 (0%) | 0% | 51.6 | 12,183 | Common Stock |
Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 47.81 per share. | 21 Dec 2020 | 3,935 | 802,547 (0%) | 0% | 47.8 | 188,141 | Common Stock |
Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 54.27 per share. | 21 Dec 2020 | 7,011 | 584,749 (0%) | 0% | 54.3 | 380,491 | Common Stock |
Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 53.43 per share. | 21 Dec 2020 | 42,338 | 591,760 (0%) | 0% | 53.4 | 2,262,306 | Common Stock |
Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 52.84 per share. | 21 Dec 2020 | 70,942 | 634,098 (0%) | 0% | 52.8 | 3,748,696 | Common Stock |
Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 51.73 per share. | 21 Dec 2020 | 4,700 | 705,040 (0%) | 0% | 51.7 | 243,114 | Common Stock |
Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 50.54 per share. | 21 Dec 2020 | 200 | 709,740 (0%) | 0% | 50.5 | 10,109 | Common Stock |
Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 49.95 per share. | 21 Dec 2020 | 73,310 | 709,940 (0%) | 0% | 49.9 | 3,661,827 | Common Stock |
Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 49.24 per share. | 21 Dec 2020 | 19,297 | 783,250 (0%) | 0% | 49.2 | 950,238 | Common Stock |
Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 47.10 per share. | 21 Dec 2020 | 3,232 | 806,482 (0%) | 0% | 47.1 | 152,218 | Common Stock |
Eric Aguiar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2020 | 10,000 | 0 | - | - | Stock Option (right to buy) | |
Eric Aguiar | Director | Sale of securities on an exchange or to another person at price $ 50.74 per share. | 16 Dec 2020 | 6,400 | 3,600 (0%) | 0% | 50.7 | 324,723 | Common Stock |
Eric Aguiar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.16 per share. | 16 Dec 2020 | 10,000 | 10,000 (0%) | 0% | 24.2 | 241,600 | Common Stock |
Eric Aguiar | Director | Sale of securities on an exchange or to another person at price $ 51.47 per share. | 16 Dec 2020 | 3,600 | 0 (0%) | 0% | 51.5 | 185,280 | Common Stock |
Kenneth D. Knight | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 51.00 per share. | 16 Dec 2020 | 13,351 | 311,649 (0%) | 0% | 51 | 680,901 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 57.85 per share. | 14 Dec 2020 | 5,900 | 220,840 (0%) | 0% | 57.9 | 341,315 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 59.45 per share. | 14 Dec 2020 | 2,801 | 218,039 (0%) | 0% | 59.4 | 166,519 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 60.33 per share. | 14 Dec 2020 | 10,341 | 207,698 (0%) | 0% | 60.3 | 623,873 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 54.57 per share. | 14 Dec 2020 | 4,795 | 232,557 (0%) | 0% | 54.6 | 261,663 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 61.06 per share. | 14 Dec 2020 | 4,646 | 203,052 (0%) | 0% | 61.1 | 283,685 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 56.84 per share. | 14 Dec 2020 | 2,717 | 226,740 (0%) | 0% | 56.8 | 154,434 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 55.67 per share. | 14 Dec 2020 | 3,100 | 229,457 (0%) | 0% | 55.7 | 172,577 | Common Stock |
Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 47.32 per share. | 14 Dec 2020 | 71,869 | 1,291,757 (1%) | 0% | 47.3 | 3,400,877 | Common Stock |
Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 48.78 per share. | 14 Dec 2020 | 200 | 809,714 (0%) | 0% | 48.8 | 9,755 | Common Stock |
Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 48.18 per share. | 14 Dec 2020 | 49,474 | 809,914 (0%) | 0% | 48.2 | 2,383,697 | Common Stock |
Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 47.39 per share. | 14 Dec 2020 | 81,677 | 859,388 (0%) | 0% | 47.4 | 3,870,371 | Common Stock |
Jason W. Myers | Director, President, Oncology | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Dec 2020 | 300,000 | 941,065 (0%) | 0% | 0 | Common Stock | |
Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 48.23 per share. | 14 Dec 2020 | 5,270 | 1,241,065 (1%) | 0% | 48.2 | 254,187 | Common Stock |
Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 47.27 per share. | 14 Dec 2020 | 33,340 | 1,246,335 (1%) | 0% | 47.3 | 1,576,075 | Common Stock |
Jason W. Myers | Director, President, Oncology | Sale of securities on an exchange or to another person at price $ 46.64 per share. | 14 Dec 2020 | 12,082 | 1,279,675 (1%) | 0% | 46.6 | 563,474 | Common Stock |
Jason W. Myers | Director, President, Oncology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2020 | 152,527 | 1,363,626 (1%) | 0% | - | Common Stock | |
Jason W. Myers | Director, President, Oncology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2020 | 171,872 | 1,211,099 (1%) | 0% | - | Common Stock | |
Sean E. George | President & CEO | Sale of securities on an exchange or to another person at price $ 46.85 per share. | 20 Nov 2020 | 1,100 | 642,276 (0%) | 0% | 46.9 | 51,535 | Common Stock |
Sean E. George | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.70 per share. | 20 Nov 2020 | 5,000 | 643,376 (0%) | 0% | 8.7 | 43,500 | Common Stock |
Sean E. George | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2020 | 5,000 | 45,000 | - | - | Employee Stock Options (right to buy) | |
Sean E. George | President & CEO | Sale of securities on an exchange or to another person at price $ 48.61 per share. | 20 Nov 2020 | 906 | 634,693 (0%) | 0% | 48.6 | 44,041 | Common Stock |
Sean E. George | President & CEO | Sale of securities on an exchange or to another person at price $ 48.08 per share. | 20 Nov 2020 | 6,677 | 635,599 (0%) | 0% | 48.1 | 321,030 | Common Stock |
Shelly D. Guyer | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 46.20 per share. | 18 Nov 2020 | 1,513 | 226,007 (0%) | 0% | 46.2 | 69,901 | Common Stock |
Shelly D. Guyer | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 47.17 per share. | 18 Nov 2020 | 1,187 | 224,820 (0%) | 0% | 47.2 | 55,991 | Common Stock |
Shelly D. Guyer | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 47.91 per share. | 18 Nov 2020 | 300 | 224,520 (0%) | 0% | 47.9 | 14,373 | Common Stock |
Thomas R. Brida | General Counsel | Sale of securities on an exchange or to another person at price $ 45.96 per share. | 17 Nov 2020 | 4,400 | 208,476 (0%) | 0% | 46.0 | 202,224 | Common Stock |
Thomas R. Brida | General Counsel | Sale of securities on an exchange or to another person at price $ 46.38 per share. | 17 Nov 2020 | 600 | 207,876 (0%) | 0% | 46.4 | 27,828 | Common Stock |
Eric Aguiar | Director | Sale of securities on an exchange or to another person at price $ 46.36 per share. | 16 Nov 2020 | 22,883 | 7,117 (0%) | 0% | 46.4 | 1,060,856 | Common Stock |
Eric Aguiar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.51 per share. | 16 Nov 2020 | 10,000 | 10,000 (0%) | 0% | 8.5 | 85,100 | Common Stock |
Eric Aguiar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.18 per share. | 16 Nov 2020 | 10,000 | 20,000 (0%) | 0% | 9.2 | 91,800 | Common Stock |
Eric Aguiar | Director | Sale of securities on an exchange or to another person at price $ 47.05 per share. | 16 Nov 2020 | 7,117 | 0 (0%) | 0% | 47.1 | 334,855 | Common Stock |
Eric Aguiar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.13 per share. | 16 Nov 2020 | 10,000 | 30,000 (0%) | 0% | 11.1 | 111,300 | Common Stock |
Eric Aguiar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2020 | 10,000 | 0 | - | - | Stock Option (right to buy) | |
Eric Aguiar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2020 | 10,000 | 0 | - | - | Stock Option (right to buy) | |
Eric Aguiar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2020 | 10,000 | 0 | - | - | Stock Option (right to buy) | |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 48.00 per share. | 13 Nov 2020 | 1,000 | 237,352 (0%) | 0% | 48 | 48,000 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 51.36 per share. | 13 Oct 2020 | 1,000 | 238,352 (0%) | 0% | 51.4 | 51,360 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Oct 2020 | 6,550 | 63,450 | - | - | Employee Stock Options (right to buy) | |
Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.90 per share. | 09 Oct 2020 | 6,550 | 215,211 (0%) | 0% | 9.9 | 64,845 | Common Stock |
Robert F. Werner | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 46.91 per share. | 05 Oct 2020 | 437 | 60,388 (0%) | 0% | 46.9 | 20,500 | Common Stock |
Robert F. Werner | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 48.37 per share. | 05 Oct 2020 | 1,051 | 59,337 (0%) | 0% | 48.4 | 50,837 | Common Stock |
Robert F. Werner | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 49.99 per share. | 05 Oct 2020 | 439 | 58,898 (0%) | 0% | 50.0 | 21,946 | Common Stock |
Robert F. Werner | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 50.56 per share. | 05 Oct 2020 | 400 | 58,498 (0%) | 0% | 50.6 | 20,224 | Common Stock |
Robert F. Werner | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 52.12 per share. | 05 Oct 2020 | 100 | 58,398 (0%) | 0% | 52.1 | 5,212 | Common Stock |
Robert F. Werner | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2020 | 30,000 | 60,334 (0%) | 0% | 0 | Common Stock | |
Jason W. Myers | Director, President, Oncology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2020 | 1,039,227 | 1,039,227 (1%) | 1% | - | Common Stock | |
Jason W. Myers | Director, President, Oncology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2020 | 643,839 | 643,839 | - | - | Stock Option (right to buy) | |
Jason W. Myers | Director, President, Oncology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2020 | 278,417 | 278,417 | - | - | Stock Option (right to buy) | |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 35.51 per share. | 15 Sep 2020 | 1,000 | 239,352 (0%) | 0% | 35.5 | 35,510 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 33.87 per share. | 10 Sep 2020 | 631 | 240,352 (0%) | 0% | 33.9 | 21,370 | Common Stock |
Shelly D. Guyer | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 33.87 per share. | 10 Sep 2020 | 631 | 227,520 (0%) | 0% | 33.9 | 21,370 | Common Stock |
Robert F. Werner | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 33.87 per share. | 10 Sep 2020 | 246 | 30,334 (0%) | 0% | 33.9 | 8,331 | Common Stock |
Sean E. George | President & CEO | Sale of securities on an exchange or to another person at price $ 33.87 per share. | 10 Sep 2020 | 742 | 638,376 (0%) | 0% | 33.9 | 25,129 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 32.97 per share. | 10 Sep 2020 | 9,391 | 221,888 (0%) | 0% | 33.0 | 309,591 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 33.87 per share. | 10 Sep 2020 | 557 | 231,279 (0%) | 0% | 33.9 | 18,864 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 33.86 per share. | 10 Sep 2020 | 11,497 | 210,391 (0%) | 0% | 33.9 | 389,345 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 34.69 per share. | 10 Sep 2020 | 1,730 | 208,661 (0%) | 0% | 34.7 | 60,012 | Common Stock |
Thomas R. Brida | General Counsel | Sale of securities on an exchange or to another person at price $ 33.87 per share. | 10 Sep 2020 | 633 | 212,252 (0%) | 0% | 33.9 | 21,438 | Common Stock |
Kimber D. Lockhart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2020 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
Katherine A. Stueland | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2020 | 1,253 | 240,983 (0%) | 0% | 0 | Common Stock | |
Shelly D. Guyer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2020 | 1,253 | 228,151 (0%) | 0% | 0 | Common Stock | |
Robert F. Werner | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2020 | 543 | 30,580 (0%) | 0% | 0 | Common Stock | |
Sean E. George | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2020 | 1,475 | 639,118 (0%) | 0% | 0 | Common Stock | |
Robert L. Nussbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2020 | 1,106 | 231,836 (0%) | 0% | 0 | Common Stock | |
Thomas R. Brida | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2020 | 1,257 | 212,885 (0%) | 0% | 0 | Common Stock | |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 32.10 per share. | 19 Aug 2020 | 21,345 | 239,730 (0%) | 0% | 32.1 | 685,102 | Common Stock |
Shelly D. Guyer | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 32.10 per share. | 19 Aug 2020 | 18,956 | 226,898 (0%) | 0% | 32.1 | 608,417 | Common Stock |
Robert F. Werner | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 32.10 per share. | 19 Aug 2020 | 1,740 | 30,037 (0%) | 0% | 32.1 | 55,847 | Common Stock |
Sean E. George | President & CEO | Sale of securities on an exchange or to another person at price $ 32.10 per share. | 19 Aug 2020 | 15,473 | 637,643 (0%) | 0% | 32.1 | 496,629 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 32.10 per share. | 19 Aug 2020 | 19,049 | 230,730 (0%) | 0% | 32.1 | 611,399 | Common Stock |
Thomas R. Brida | General Counsel | Sale of securities on an exchange or to another person at price $ 32.10 per share. | 19 Aug 2020 | 12,416 | 211,628 (0%) | 0% | 32.1 | 398,508 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 29.31 per share. | 12 Aug 2020 | 1,000 | 261,075 (0%) | 0% | 29.3 | 29,310 | Common Stock |
Kenneth D. Knight | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2020 | 75,000 | 325,000 (0%) | 0% | 0 | Common Stock | |
Kenneth D. Knight | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2020 | 250,000 | 250,000 (0%) | 0% | 0 | Common Stock | |
Shelly D. Guyer | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 33.65 per share. | 17 Jul 2020 | 1,300 | 245,854 (0%) | 0% | 33.7 | 43,746 | Common Stock |
Shelly D. Guyer | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 33.10 per share. | 17 Jul 2020 | 10,700 | 247,154 (0%) | 0% | 33.1 | 354,181 | Common Stock |
Eric Aguiar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.08 per share. | 15 Jul 2020 | 10,000 | 10,000 (0%) | 0% | 8.1 | 80,800 | Common Stock |
Eric Aguiar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2020 | 10,000 | 0 | - | - | Stock Option (right to buy) | |
Eric Aguiar | Director | Sale of securities on an exchange or to another person at price $ 34.24 per share. | 15 Jul 2020 | 6,829 | 0 (0%) | 0% | 34.2 | 233,814 | Common Stock |
Eric Aguiar | Director | Sale of securities on an exchange or to another person at price $ 33.44 per share. | 15 Jul 2020 | 3,171 | 6,829 (0%) | 0% | 33.4 | 106,039 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 32.50 per share. | 14 Jul 2020 | 1,000 | 262,075 (0%) | 0% | 32.5 | 32,500 | Common Stock |
Lee Bendekgey | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 33.07 per share. | 13 Jul 2020 | 7,325 | 238,486 (0%) | 0% | 33.1 | 242,222 | Common Stock |
Lee Bendekgey | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jul 2020 | 27,500 | 0 | - | - | Employee Stock Option (right to buy) | |
Lee Bendekgey | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 34.96 per share. | 13 Jul 2020 | 7,730 | 218,311 (0%) | 0% | 35.0 | 270,262 | Common Stock |
Lee Bendekgey | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 34.31 per share. | 13 Jul 2020 | 12,445 | 226,041 (0%) | 0% | 34.3 | 427,025 | Common Stock |
Lee Bendekgey | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.82 per share. | 13 Jul 2020 | 27,500 | 245,811 (0%) | 0% | 2.8 | 77,550 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 34.31 per share. | 09 Jul 2020 | 22,347 | 251,229 (0%) | 0% | 34.3 | 766,634 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 34.93 per share. | 09 Jul 2020 | 1,450 | 249,779 (0%) | 0% | 34.9 | 50,649 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 33.38 per share. | 09 Jul 2020 | 5,986 | 273,576 (0%) | 0% | 33.4 | 199,829 | Common Stock |
Lee Bendekgey | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2020 | 19,600 | 19,600 | - | - | Employee Stock Option (right to buy) | |
Lee Bendekgey | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2020 | 59,150 | 218,311 (0%) | 0% | 0 | Common Stock | |
Katherine A. Stueland | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2020 | 59,150 | 263,075 (0%) | 0% | 0 | Common Stock | |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 16.34 per share. | 12 Jun 2020 | 1,000 | 203,925 (0%) | 0% | 16.3 | 16,340 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2020 | 19,600 | 19,600 | - | - | Employee Stock Option (right to buy) | |
Shelly D. Guyer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2020 | 59,150 | 257,854 (0%) | 0% | 0 | Common Stock | |
Shelly D. Guyer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2020 | 19,600 | 19,600 | - | - | Employee Stock Option (right to buy) | |
Sean E. George | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2020 | 126,550 | 653,116 (0%) | 0% | 0 | Common Stock | |
Sean E. George | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2020 | 42,200 | 42,200 | - | - | Employee Stock Option (right to buy) | |
Robert L. Nussbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2020 | 19,600 | 19,600 | - | - | Employee Stock Option (right to buy) | |
Robert L. Nussbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2020 | 59,150 | 279,562 (0%) | 0% | 0 | Common Stock | |
Thomas R. Brida | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2020 | 59,150 | 224,044 (0%) | 0% | 0 | Common Stock | |
Thomas R. Brida | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2020 | 19,600 | 19,600 | - | - | Employee Stock Option (right to buy) | |
Robert F. Werner | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2020 | 10,000 | 31,777 (0%) | 0% | 0 | Common Stock | |
Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.90 per share. | 03 Jun 2020 | 20,000 | 220,412 (0%) | 0% | 9.9 | 198,000 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2020 | 20,000 | 70,000 | - | - | Employee Stock Option (right to buy) | |
Lee Bendekgey | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.70 per share. | 20 May 2020 | 9,348 | 159,161 (0%) | 0% | 16.7 | 156,119 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 16.70 per share. | 20 May 2020 | 6,177 | 204,925 (0%) | 0% | 16.7 | 103,161 | Common Stock |
Shelly D. Guyer | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 16.70 per share. | 20 May 2020 | 5,250 | 198,704 (0%) | 0% | 16.7 | 87,679 | Common Stock |
Sean E. George | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 16.70 per share. | 20 May 2020 | 25,500 | 526,566 (0%) | 0% | 16.7 | 425,870 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 16.70 per share. | 20 May 2020 | 6,864 | 220,305 (0%) | 0% | 16.7 | 114,634 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.62 per share. | 20 May 2020 | 3,034 | 200,412 (0%) | 0% | 17.6 | 53,471 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.22 per share. | 20 May 2020 | 16,859 | 203,446 (0%) | 0% | 17.2 | 290,292 | Common Stock |
Thomas R. Brida | General Counsel | Sale of securities on an exchange or to another person at price $ 16.70 per share. | 20 May 2020 | 2,060 | 164,894 (0%) | 0% | 16.7 | 34,404 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 17.56 per share. | 13 May 2020 | 1,000 | 211,102 (0%) | 0% | 17.6 | 17,560 | Common Stock |
Lee Bendekgey | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 17.96 per share. | 12 May 2020 | 13,700 | 173,474 (0%) | 0% | 18.0 | 246,057 | Common Stock |
Lee Bendekgey | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 18.53 per share. | 12 May 2020 | 4,965 | 168,509 (0%) | 0% | 18.5 | 92,022 | Common Stock |
Christine M. Gorjanc | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
Geoffrey S. Crouse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
Chitra Nayak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 12.80 per share. | 13 Apr 2020 | 1,000 | 212,102 (0%) | 0% | 12.8 | 12,803 | Common Stock |
Lee Bendekgey | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 11.79 per share. | 12 Mar 2020 | 11,056 | 187,174 (0%) | 0% | 11.8 | 130,350 | Common Stock |
Lee Bendekgey | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2020 | 91,733 | 198,230 (0%) | 0% | 0 | Common Stock | |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 11.58 per share. | 12 Mar 2020 | 935 | 223,851 (0%) | 0% | 11.6 | 10,825 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 11.79 per share. | 12 Mar 2020 | 10,684 | 213,102 (0%) | 0% | 11.8 | 125,964 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 12.60 per share. | 12 Mar 2020 | 65 | 223,786 (0%) | 0% | 12.6 | 819 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2020 | 91,733 | 224,786 (0%) | 0% | 0 | Common Stock | |
Shelly D. Guyer | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 11.79 per share. | 12 Mar 2020 | 10,684 | 203,954 (0%) | 0% | 11.8 | 125,964 | Common Stock |
Shelly D. Guyer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2020 | 91,733 | 214,638 (0%) | 0% | 0 | Common Stock | |
Sean E. George | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2020 | 100,072 | 563,721 (0%) | 0% | 0 | Common Stock | |
Sean E. George | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 11.79 per share. | 12 Mar 2020 | 11,655 | 552,066 (0%) | 0% | 11.8 | 137,412 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 11.79 per share. | 12 Mar 2020 | 10,684 | 227,169 (0%) | 0% | 11.8 | 125,964 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2020 | 91,733 | 237,853 (0%) | 0% | 0 | Common Stock | |
Thomas R. Brida | General Counsel | Sale of securities on an exchange or to another person at price $ 11.79 per share. | 12 Mar 2020 | 9,226 | 165,868 (0%) | 0% | 11.8 | 108,775 | Common Stock |
Thomas R. Brida | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2020 | 79,224 | 175,094 (0%) | 0% | 0 | Common Stock | |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 20.44 per share. | 27 Feb 2020 | 1,000 | 133,053 (0%) | 0% | 20.4 | 20,435 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 18.14 per share. | 14 Jan 2020 | 1,000 | 134,053 (0%) | 0% | 18.1 | 18,137 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 17.08 per share. | 13 Dec 2019 | 1,000 | 135,053 (0%) | 0% | 17.1 | 17,082 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 17.46 per share. | 14 Nov 2019 | 3,788 | 136,053 (0%) | 0% | 17.5 | 66,123 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 21.40 per share. | 17 Sep 2019 | 3,788 | 139,841 (0%) | 0% | 21.4 | 81,081 | Common Stock |
Randal W. Scott | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 24.82 per share. | 26 Aug 2019 | 28,301 | 3,450,669 (3%) | 0% | 24.8 | 702,425 | Common Stock |
Randal W. Scott | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 24.02 per share. | 26 Aug 2019 | 11,699 | 3,478,970 (3%) | 0% | 24.0 | 280,980 | Common Stock |
Geoffrey S. Crouse | None | Sale of securities on an exchange or to another person at price $ 25.68 per share. | 22 Aug 2019 | 5,000 | 29,259 (0%) | 0% | 25.7 | 128,410 | Common Stock |
Lee Bendekgey | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 25.29 per share. | 19 Aug 2019 | 21,265 | 140,323 (0%) | 0% | 25.3 | 537,883 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 25.29 per share. | 19 Aug 2019 | 22,900 | 143,629 (0%) | 0% | 25.3 | 579,239 | Common Stock |
Shelly D. Guyer | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 25.85 per share. | 19 Aug 2019 | 4,000 | 143,352 (0%) | 0% | 25.8 | 103,382 | Common Stock |
Shelly D. Guyer | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 25.29 per share. | 19 Aug 2019 | 20,447 | 122,905 (0%) | 0% | 25.3 | 517,193 | Common Stock |
Sean E. George | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 25.29 per share. | 19 Aug 2019 | 16,358 | 463,649 (0%) | 0% | 25.3 | 413,764 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 25.29 per share. | 19 Aug 2019 | 20,447 | 146,120 (0%) | 0% | 25.3 | 517,193 | Common Stock |
Thomas R. Brida | General Counsel | Sale of securities on an exchange or to another person at price $ 25.29 per share. | 19 Aug 2019 | 13,663 | 95,870 (0%) | 0% | 25.3 | 345,596 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 24.98 per share. | 16 Aug 2019 | 3,789 | 166,529 (0%) | 0% | 25.0 | 94,645 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 22.49 per share. | 15 Jul 2019 | 3,789 | 170,318 (0%) | 0% | 22.5 | 85,231 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 19.36 per share. | 13 Jun 2019 | 3,789 | 174,107 (0%) | 0% | 19.4 | 73,356 | Common Stock |
Randal W. Scott | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 17.60 per share. | 28 May 2019 | 30,000 | 3,490,669 (3%) | 0% | 17.6 | 528,027 | Common Stock |
Lee Bendekgey | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 18.21 per share. | 20 May 2019 | 6,851 | 161,588 (0%) | 0% | 18.2 | 124,757 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 18.21 per share. | 20 May 2019 | 6,474 | 177,896 (0%) | 0% | 18.2 | 117,892 | Common Stock |
Shelly D. Guyer | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 17.79 per share. | 20 May 2019 | 4,000 | 152,865 (0%) | 0% | 17.8 | 71,148 | Common Stock |
Shelly D. Guyer | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.21 per share. | 20 May 2019 | 5,513 | 147,352 (0%) | 0% | 18.2 | 100,392 | Common Stock |
Sean E. George | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 18.21 per share. | 20 May 2019 | 24,282 | 480,007 (0%) | 0% | 18.2 | 442,175 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 18.21 per share. | 20 May 2019 | 7,202 | 166,567 (0%) | 0% | 18.2 | 131,148 | Common Stock |
Thomas R. Brida | General Counsel | Sale of securities on an exchange or to another person at price $ 18.21 per share. | 20 May 2019 | 2,146 | 109,533 (0%) | 0% | 18.2 | 39,079 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 18.36 per share. | 15 May 2019 | 1,000 | 184,370 (0%) | 0% | 18.4 | 18,360 | Common Stock |
Lee Bendekgey | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 18.78 per share. | 14 May 2019 | 4,657 | 168,439 (0%) | 0% | 18.8 | 87,439 | Common Stock |
Randal W. Scott | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2019 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
Chitra Nayak | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2019 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
Geoffrey S. Crouse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2019 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2019 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
Sean E. George | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2019 | 145,000 | 145,000 | - | - | Employee Stock Option (right to buy) | |
Christine M. Gorjanc | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2019 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 25.23 per share. | 16 Apr 2019 | 1,000 | 185,370 (0%) | 0% | 25.2 | 25,230 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 23.49 per share. | 15 Mar 2019 | 1,000 | 186,370 (0%) | 0% | 23.5 | 23,490 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2019 | 10,000 | 90,000 | - | - | Employee Stock Option (right to buy) | |
Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.90 per share. | 08 Mar 2019 | 10,000 | 173,769 (0%) | 0% | 9.9 | 99,000 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 19.61 per share. | 27 Feb 2019 | 1,000 | 187,370 (0%) | 0% | 19.6 | 19,610 | Common Stock |
Shelly D. Guyer | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 20.52 per share. | 27 Feb 2019 | 593 | 156,865 (0%) | 0% | 20.5 | 12,168 | Common Stock |
Shelly D. Guyer | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 19.91 per share. | 27 Feb 2019 | 3,407 | 157,458 (0%) | 0% | 19.9 | 67,850 | Common Stock |
Patricia E. Dumond | See Remarks | Sale of securities on an exchange or to another person at price $ 19.71 per share. | 27 Feb 2019 | 5,000 | 88,811 (0%) | 0% | 19.7 | 98,540 | Common Stock |
Lee Bendekgey | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 19.62 per share. | 26 Feb 2019 | 4,650 | 173,096 (0%) | 0% | 19.6 | 91,213 | Common Stock |
Randal W. Scott | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 19.66 per share. | 25 Feb 2019 | 1,000 | 3,520,669 (3%) | 0% | 19.7 | 19,657 | Common Stock |
Randal W. Scott | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 19.08 per share. | 25 Feb 2019 | 29,000 | 3,521,669 (3%) | 0% | 19.1 | 553,340 | Common Stock |
Shelly D. Guyer | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.49 per share. | 16 Jan 2019 | 4,000 | 160,865 (0%) | 0% | 14.5 | 57,968 | Common Stock |
Patricia E. Dumond | See Remarks | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 16 Jan 2019 | 3,000 | 93,811 (0%) | 0% | 15 | 45,000 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 13.59 per share. | 15 Jan 2019 | 1,000 | 188,370 (0%) | 0% | 13.6 | 13,590 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 14.01 per share. | 10 Jan 2019 | 5,222 | 163,769 (0%) | 0% | 14.0 | 73,153 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 11.44 per share. | 17 Dec 2018 | 1,000 | 189,370 (0%) | 0% | 11.4 | 11,437 | Common Stock |
Eric Aguiar | None | Sale of securities on an exchange or to another person at price $ 13.50 per share. | 27 Nov 2018 | 10,000 | 0 (0%) | 0% | 13.5 | 135,000 | Common Stock |
Patricia E. Dumond | See Remarks | Sale of securities on an exchange or to another person at price $ 12.90 per share. | 16 Nov 2018 | 2,000 | 96,811 (0%) | 0% | 12.9 | 25,800 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.66 per share. | 15 Nov 2018 | 1,593 | 190,370 (0%) | 0% | 12.7 | 20,173 | Common Stock |
Lee Bendekgey | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.23 per share. | 14 Nov 2018 | 4,650 | 177,746 (0%) | 0% | 12.2 | 56,870 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 13.53 per share. | 12 Nov 2018 | 2,200 | 168,991 (0%) | 0% | 13.5 | 29,762 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 12 Nov 2018 | 8,244 | 171,191 (0%) | 0% | 13.0 | 107,202 | Common Stock |
Patricia E. Dumond | See Remarks | Sale of securities on an exchange or to another person at price $ 16.51 per share. | 18 Sep 2018 | 355 | 98,811 (0%) | 0% | 16.5 | 5,861 | Common Stock |
Patricia E. Dumond | See Remarks | Sale of securities on an exchange or to another person at price $ 16.67 per share. | 18 Sep 2018 | 290 | 99,166 (0%) | 0% | 16.7 | 4,834 | Common Stock |
Chitra Nayak | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2018 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 13.62 per share. | 09 Sep 2018 | 595 | 191,963 (0%) | 0% | 13.6 | 8,104 | Common Stock |
Christine M. Gorjanc | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2018 | 10,000 | 10,000 | - | - | Employee Stock Option (right to buy) | |
Lee Bendekgey | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2018 | 130,000 | 182,396 (0%) | 0% | 0 | Common | |
Randal W. Scott | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2018 | 10,000 | 10,000 | - | - | Employee Stock Option (right to buy) | |
Geoffrey S. Crouse | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2018 | 10,000 | 10,000 | - | - | Employee Stock Option (right to buy) | |
Eric Aguiar | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2018 | 10,000 | 10,000 | - | - | Employee Stock Option (right to buy) | |
Katherine A. Stueland | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2018 | 140,000 | 192,558 (0%) | 0% | 0 | Common Stock | |
Shelly D. Guyer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2018 | 125,000 | 164,865 (0%) | 0% | 0 | Common Stock | |
Sean E. George | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2018 | 200,000 | 200,000 | - | - | Employee Stock Option (right to buy) | |
Sean E. George | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2018 | 100,000 | 504,289 (0%) | 0% | 0 | Common Stock | |
Patricia E. Dumond | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2018 | 45,000 | 99,456 (0%) | 0% | 0 | Common Stock | |
Robert L. Nussbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2018 | 125,000 | 179,435 (0%) | 0% | 0 | Common Stock | |
Thomas R. Brida | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2018 | 85,000 | 110,973 (0%) | 0% | 0 | Common Stock | |
Lee Bendekgey | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.96 per share. | 15 May 2018 | 6,388 | 52,396 (0%) | 0% | 7.0 | 44,460 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 6.96 per share. | 15 May 2018 | 6,012 | 52,558 (0%) | 0% | 7.0 | 41,844 | Common Stock |
Shelly D. Guyer | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.96 per share. | 15 May 2018 | 5,135 | 39,865 (0%) | 0% | 7.0 | 35,740 | Common Stock |
Sean E. George | President & CEO | Sale of securities on an exchange or to another person at price $ 6.96 per share. | 15 May 2018 | 20,311 | 409,289 (0%) | 0% | 7.0 | 141,365 | Common Stock |
Patricia E. Dumond | See Remarks | Sale of securities on an exchange or to another person at price $ 6.96 per share. | 15 May 2018 | 5,014 | 54,456 (0%) | 0% | 7.0 | 34,897 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 6.96 per share. | 15 May 2018 | 6,702 | 54,435 (0%) | 0% | 7.0 | 46,646 | Common Stock |
Thomas R. Brida | General Counsel | Sale of securities on an exchange or to another person at price $ 6.96 per share. | 15 May 2018 | 1,979 | 25,973 (0%) | 0% | 7.0 | 13,774 | Common Stock |
Randal W. Scott | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 4.50 per share. | 02 Apr 2018 | 44,444 | 3,550,669 (5%) | 0% | 4.5 | 199,998 | Common Stock |
Patricia E. Dumond | VP Fin. & Principal Acct. Off. | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 09 Oct 2017 | 615 | 52,168 (0%) | 0% | 10 | 6,150 | Common Stock |
Patricia E. Dumond | VP Fin. & Principal Acct. Off. | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 09 Oct 2017 | 1,882 | 52,783 (0%) | 0% | 10 | 18,820 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 9.40 per share. | 12 Sep 2017 | 612 | 58,570 (0%) | 0% | 9.4 | 5,753 | Common Stock |
Shelly D. Guyer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2017 | 45,000 | 45,000 (0%) | 0% | 0 | Common Stock | |
Shelly D. Guyer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2017 | 100,000 | 100,000 | - | - | Employee Stock Options (right to buy) | |
Christine M. Gorjanc | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2017 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
Randal W. Scott | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2017 | 10,000 | 10,000 | - | - | Employee Stock Option (right to buy) | |
Geoffrey S. Crouse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2017 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2017 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
Thomas R. Brida | General Counsel | Sale of securities on an exchange or to another person at price $ 9.69 per share. | 16 Feb 2017 | 766 | 24,720 (0%) | 0% | 9.7 | 7,420 | Common Stock |
Lee Bendekgey | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2017 | 5,000 | 60,882 (0%) | 0% | 0 | Common Stock | |
Lee Bendekgey | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 9.59 per share. | 13 Feb 2017 | 2,098 | 58,784 (0%) | 0% | 9.6 | 20,120 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 9.50 per share. | 13 Feb 2017 | 911 | 59,182 (0%) | 0% | 9.5 | 8,655 | Common Stock |
Katherine A. Stueland | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2017 | 2,152 | 60,093 (0%) | 0% | 0 | Common Stock | |
Sean E. George | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2017 | 5,000 | 416,878 (0%) | 0% | 0 | Common Stock | |
Patricia E. Dumond | VP Fin. & Principal Acct. Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2017 | 3,000 | 55,929 (0%) | 0% | 0 | Common Stock | |
Patricia E. Dumond | VP Fin. & Principal Acct. Off. | Sale of securities on an exchange or to another person at price $ 9.55 per share. | 13 Feb 2017 | 1,264 | 54,665 (0%) | 0% | 9.5 | 12,068 | Common Stock |
Robert L. Nussbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2017 | 4,000 | 62,823 (0%) | 0% | 0 | Common Stock | |
Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 9.53 per share. | 13 Feb 2017 | 1,686 | 61,137 (0%) | 0% | 9.5 | 16,068 | Common Stock |
Thomas R. Brida | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2017 | 1,883 | 26,280 (0%) | 0% | 0 | Common Stock | |
Thomas R. Brida | General Counsel | Sale of securities on an exchange or to another person at price $ 9.54 per share. | 13 Feb 2017 | 794 | 25,486 (0%) | 0% | 9.5 | 7,573 | Common Stock |
Lee Bendekgey | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2017 | 55,882 | 55,882 (0%) | 0% | 0 | Common Stock | |
Katherine A. Stueland | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2017 | 52,941 | 57,941 (0%) | 0% | 0 | Common Stock | |
Sean E. George | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2017 | 176,470 | 411,878 (0%) | 0% | 0 | Common Stock | |
Sean E. George | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2017 | 252,648 | 252,648 | - | - | Employee Stock Option (right to buy) | |
Patricia E. Dumond | VP Fin. & Principal Acct. Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2017 | 44,117 | 52,929 (0%) | 0% | 0 | Common Stock | |
Robert L. Nussbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2017 | 58,823 | 58,823 (0%) | 0% | 0 | Common Stock | |
Thomas R. Brida | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2017 | 17,647 | 24,397 (0%) | 0% | 0 | Common Stock | |
Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2017 | 1,666 | 0 | - | - | Stock Option (right to buy) | |
Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.26 per share. | 03 Jan 2017 | 1,666 | 1,666 (0%) | 0% | 1.3 | 2,099 | Common Stock |
Randal W. Scott | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Nov 2016 | 66,666 | 3,506,225 | - | - | Common Stock | |
Eric Aguiar | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 18 Nov 2016 | 10,000 | 10,000 | - | - | Common Stock | |
Geoffrey S. Crouse | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 18 Nov 2016 | 15,000 | 34,259 | - | - | Common Stock | |
Julian C. Baker | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 17 Nov 2016 | 69,074 | 734,261 | - | - | Common Stock | |
Julian C. Baker | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 17 Nov 2016 | 664,259 | 6,480,668 | - | - | Common Stock | |
Patricia E. Dumond | VP Fin. & Principal Acct. Off. | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 16 Sep 2016 | 1,000 | 8,812 | - | - | Common Stock | |
Patricia E. Dumond | VP Fin. & Principal Acct. Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2016 | 1,000 | 9,812 | - | - | Common Stock | |
Patricia E. Dumond | VP Fin. & Principal Acct. Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2016 | 1,000 | 2,333 | - | - | Employee Stock Option (right to buy) | |
Patricia E. Dumond | VP Fin. & Principal Acct. Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2016 | 1,000 | 9,812 | - | - | Common Stock | |
Patricia E. Dumond | VP Fin. & Principal Acct. Off. | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 15 Aug 2016 | 1,000 | 8,812 | - | - | Common Stock | |
Patricia E. Dumond | VP Fin. & Principal Acct. Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2016 | 1,000 | 6,333 | - | - | Employee Stock Option (right to buy) | |
Patricia E. Dumond | VP Fin. & Principal Acct. Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2016 | 1,000 | 9,812 | - | - | Common Stock | |
Patricia E. Dumond | VP Fin. & Principal Acct. Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2016 | 1,000 | 7,333 | - | - | Employee Stock Option (right to buy) | |
Patricia E. Dumond | VP Fin. & Principal Acct. Off. | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 14 Jul 2016 | 1,000 | 8,812 | - | - | Common Stock | |
Patricia E. Dumond | VP Fin. & Principal Acct. Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2016 | 1,000 | 8,333 | - | - | Employee Stock Option (right to buy) | |
Patricia E. Dumond | VP Fin. & Principal Acct. Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2016 | 1,000 | 9,812 | - | - | Common Stock | |
Patricia E. Dumond | VP Fin. & Principal Acct. Off. | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 16 Jun 2016 | 1,000 | 8,812 | - | - | Common Stock | |
Patricia E. Dumond | VP Fin. & Principal Acct. Off. | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 16 May 2016 | 2,221 | 8,812 | - | - | Common Stock | |
Patricia E. Dumond | VP Fin. & Principal Acct. Off. | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 16 May 2016 | 1,000 | 11,033 | - | - | Common Stock | |
Patricia E. Dumond | VP Fin. & Principal Acct. Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2016 | 1,000 | 12,033 | - | - | Common Stock | |
Patricia E. Dumond | VP Fin. & Principal Acct. Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2016 | 1,000 | 9,333 | - | - | Employee Stock Option (right to buy) |